Literature DB >> 31843894

Stress-induced modulation of endocannabinoid signaling leads to delayed strengthening of synaptic connectivity in the amygdala.

Farhana Yasmin1,2, Roberto Colangeli3, Maria Morena3, Sarah Filipski4, Mario van der Stelt5, Quentin J Pittman3,6, Cecilia J Hillard7,8, G Campbell Teskey3,9, Bruce S McEwen10, Matthew N Hill11,4, Sumantra Chattarji12,2,13.   

Abstract

Even a brief exposure to severe stress strengthens synaptic connectivity days later in the amygdala, a brain area implicated in the affective symptoms of stress-related psychiatric disorders. However, little is known about the synaptic signaling mechanisms during stress that eventually culminate in its delayed impact on the amygdala. Hence, we investigated early stress-induced changes in amygdalar synaptic signaling in order to prevent its delayed effects. Whole-cell recordings in basolateral amygdala (BLA) slices from rats revealed higher frequency of miniature excitatory postsynaptic currents (mEPSCs) immediately after 2-h immobilization stress. This was replicated by inhibition of cannabinoid receptors (CB1R), suggesting a role for endocannabinoid (eCB) signaling. Stress also reduced N-arachidonoylethanolamine (AEA), an endogenous ligand of CB1R. Since stress-induced activation of fatty acid amide hydrolase (FAAH) reduces AEA, we confirmed that oral administration of an FAAH inhibitor during stress prevents the increase in synaptic excitation in the BLA soon after stress. Although stress also caused an immediate reduction in synaptic inhibition, this was not prevented by FAAH inhibition. Strikingly, FAAH inhibition during the traumatic stressor was also effective 10 d later on the delayed manifestation of synaptic strengthening in BLA neurons, preventing both enhanced mEPSC frequency and increased dendritic spine-density. Thus, oral administration of an FAAH inhibitor during a brief stress prevents the early synaptic changes that eventually build up to hyperexcitability in the amygdala. This framework is of therapeutic relevance because of growing interest in targeting eCB signaling to prevent the gradual development of emotional symptoms and underlying amygdalar dysfunction triggered by traumatic stress.

Entities:  

Keywords:  BLA; FAAH; eCB; stress

Mesh:

Substances:

Year:  2019        PMID: 31843894      PMCID: PMC6955336          DOI: 10.1073/pnas.1910322116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Morphological changes in dendritic spines associated with long-term synaptic plasticity.

Authors:  R Yuste; T Bonhoeffer
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

2.  Alterations in corticolimbic dendritic morphology and emotional behavior in cannabinoid CB1 receptor-deficient mice parallel the effects of chronic stress.

Authors:  Matthew N Hill; Cecilia J Hillard; Bruce S McEwen
Journal:  Cereb Cortex       Date:  2011-01-24       Impact factor: 5.357

Review 3.  Neurobiological Interactions Between Stress and the Endocannabinoid System.

Authors:  Maria Morena; Sachin Patel; Jaideep S Bains; Matthew N Hill
Journal:  Neuropsychopharmacology       Date:  2015-06-12       Impact factor: 7.853

4.  Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate.

Authors:  John M Keith; Rich Apodaca; Mark Tichenor; Wei Xiao; William Jones; Joan Pierce; Mark Seierstad; James Palmer; Michael Webb; Mark Karbarz; Brian Scott; Sandy Wilson; Lin Luo; Michelle Wennerholm; Leon Chang; Sean Brown; Michele Rizzolio; Raymond Rynberg; Sandra Chaplan; J Guy Breitenbucher
Journal:  ACS Med Chem Lett       Date:  2012-08-22       Impact factor: 4.345

5.  Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling.

Authors:  Sachin Patel; Craig T Roelke; David J Rademacher; Cecilia J Hillard
Journal:  Eur J Neurosci       Date:  2005-02       Impact factor: 3.386

Review 6.  Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder.

Authors:  Matthew N Hill; Patrizia Campolongo; Rachel Yehuda; Sachin Patel
Journal:  Neuropsychopharmacology       Date:  2017-07-26       Impact factor: 7.853

7.  Constitutive Increases in Amygdalar Corticotropin-Releasing Factor and Fatty Acid Amide Hydrolase Drive an Anxious Phenotype.

Authors:  Luis A Natividad; Matthew W Buczynski; Melissa A Herman; Dean Kirson; Christopher S Oleata; Cristina Irimia; Ilham Polis; Roberto Ciccocioppo; Marisa Roberto; Loren H Parsons
Journal:  Biol Psychiatry       Date:  2017-01-13       Impact factor: 13.382

Review 8.  Response variation following trauma: a translational neuroscience approach to understanding PTSD.

Authors:  Rachel Yehuda; Joseph LeDoux
Journal:  Neuron       Date:  2007-10-04       Impact factor: 17.173

9.  Stress leads to contrasting effects on the levels of brain derived neurotrophic factor in the hippocampus and amygdala.

Authors:  Harini Lakshminarasimhan; Sumantra Chattarji
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

10.  The delayed strengthening of synaptic connectivity in the amygdala depends on NMDA receptor activation during acute stress.

Authors:  Farhana Yasmin; Kapil Saxena; Bruce S McEwen; Sumantra Chattarji
Journal:  Physiol Rep       Date:  2016-10
View more
  15 in total

1.  Anandamide Signaling Augmentation Rescues Amygdala Synaptic Function and Comorbid Emotional Alterations in a Model of Epilepsy.

Authors:  Roberto Colangeli; Maria Morena; Quentin J Pittman; Matthew N Hill; G Campbell Teskey
Journal:  J Neurosci       Date:  2020-06-29       Impact factor: 6.167

2.  "Corting" stress: post-stress corticosterone administration prevents delayed-onset biobehavioral consequences.

Authors:  Farhana Yasmin; Sachin Patel
Journal:  Neuropsychopharmacology       Date:  2020-08-11       Impact factor: 7.853

3.  Corticosterone after acute stress prevents the delayed effects on the amygdala.

Authors:  Prabahan Chakraborty; Siddhartha Datta; Bruce S McEwen; Sumantra Chattarji
Journal:  Neuropsychopharmacology       Date:  2020-07-06       Impact factor: 7.853

Review 4.  A review of the effects of acute and chronic cannabinoid exposure on the stress response.

Authors:  Nicholas C Glodosky; Carrie Cuttler; Ryan J McLaughlin
Journal:  Front Neuroendocrinol       Date:  2021-08-28       Impact factor: 8.333

Review 5.  Endocannabinoids at the synapse and beyond: implications for neuropsychiatric disease pathophysiology and treatment.

Authors:  Andrew Scheyer; Farhana Yasmin; Saptarnab Naskar; Sachin Patel
Journal:  Neuropsychopharmacology       Date:  2022-09-13       Impact factor: 8.294

Review 6.  Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome.

Authors:  Stuart M Brierley; Beverley Greenwood-Van Meerveld; Giovanni Sarnelli; Keith A Sharkey; Martin Storr; Jan Tack
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-09-27       Impact factor: 73.082

Review 7.  Meet Your Stress Management Professionals: The Endocannabinoids.

Authors:  Terri A deRoon-Cassini; Todd M Stollenwerk; Margaret Beatka; Cecilia J Hillard
Journal:  Trends Mol Med       Date:  2020-08-28       Impact factor: 11.951

8.  A common genetic variant in fatty acid amide hydrolase is linked to alterations in fear extinction neural circuitry in a racially diverse, nonclinical sample of adults.

Authors:  Nicole L Zabik; Allesandra S Iadipaolo; Hilary A Marusak; Craig Peters; Kyle Burghardt; Christine A Rabinak
Journal:  J Neurosci Res       Date:  2021-05-29       Impact factor: 4.164

Review 9.  Maturation of amygdala inputs regulate shifts in social and fear behaviors: A substrate for developmental effects of stress.

Authors:  Nicole C Ferrara; Sydney Trask; J Amiel Rosenkranz
Journal:  Neurosci Biobehav Rev       Date:  2021-02-10       Impact factor: 9.052

10.  Sex-dependent effects of endocannabinoid modulation of conditioned fear extinction in rats.

Authors:  Maria Morena; Andrei S Nastase; Alessia Santori; Benjamin F Cravatt; Rebecca M Shansky; Matthew N Hill
Journal:  Br J Pharmacol       Date:  2021-01-13       Impact factor: 9.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.